TetraGenetics

1 follower


We focus on drug discovery and development for autoimmune disease and pain targets leveraging recombinant ion channel expression.

Industries

Employees

11-50

Links

Org chart

Doug Kahn
Chairman, CEO & President

Doug Kahn

Collapse
Paul Colussi
SVP, Research
Charlotte Mcdonagh
SVP, Development and Translational Science